Rogers' bioterrorism bill clears House
Lansing State Journal
http://www.lsj.com/apps/pbcs.dll/article?AID=/20060927/NEWS01/609270371/1001/news
By Katherine Hutt Scott
The U.S. House has approved a bill co-authored by Rep. Mike Rogers that would advance research and development of drugs, vaccines and other responses to bioterrorism and disease outbreaks such as avian flu.
The House approved the noncontroversial bill by voice vote late Tuesday. The measure still must clear the Senate and be signed by President Bush.
Sylvia Warner, a spokeswoman for Rogers, R-Brighton, said the bill would provide a boost to vaccine manufacturers, including Lansing-based BioPort Corp.
The company has a contract with the federal government to make anthrax vaccine for a stockpile of medicines that would protect Americans during a terrorist attack.
http://www.lsj.com/apps/pbcs.dll/article?AID=/20060927/NEWS01/609270371/1001/news
By Katherine Hutt Scott
The U.S. House has approved a bill co-authored by Rep. Mike Rogers that would advance research and development of drugs, vaccines and other responses to bioterrorism and disease outbreaks such as avian flu.
The House approved the noncontroversial bill by voice vote late Tuesday. The measure still must clear the Senate and be signed by President Bush.
Sylvia Warner, a spokeswoman for Rogers, R-Brighton, said the bill would provide a boost to vaccine manufacturers, including Lansing-based BioPort Corp.
The company has a contract with the federal government to make anthrax vaccine for a stockpile of medicines that would protect Americans during a terrorist attack.
